UnknownPhase 4

Effect of Compound Sodium Chlorate and Aminophylline Tablets on Chronic Obstructive Pulmonary Disease(COPD).

China200 participantsStarted 2019-04-01

Plain-language summary

Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is an important event in the management of chronic obstructive pulmonary disease. Compound sodium chlolate and aminophylline tablets are one of the most widely used drugs for the treatment of bronchial asthma and chronic bronchitis.

Who can participate

Age range40 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: \- (1)All subjects must sign an informed consent form before participating in the clinical trial. (2)Clinical diagnosis of AECOPD. (3)Must be able to swallow tablets. Exclusion Criteria: * (1)Heart disease. (2)Insulin dependent diabetes. (3)Tumor disease. (4)Thyroid disease. (5)Infectious diseases such as hepatitis B, active tuberculosis, etc. (6)Active peptic ulcer. (7)Allergic to related treatments. (8)Participate in other clinical trials within three months. (9)Women who are breast-feeding, pregnant or preparing for pregnancy.

What they're measuring

COPD assessment test(CAT) score

Timeframe: The above test was given to the experimental group and the control group on the first, fourth, and eighth days after the treatment.

Potential of Hydrogen(PH),Partial pressure of oxygen(PO2),Partial pressure of carbon dioxide(PCO2)

Timeframe: The above test was given to the experimental group and the control group on the first, fourth, and eighth days after the treatment.

Trial details

NCT IDNCT04101500

SponsorUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-12-30

Contact for this trial

Yang Jin

027-85726114 whuhjy@126.com

View on ClinicalTrials.gov More Acute Exacerbation of Chronic Obstructive Pulmonary Disease trials

Plain-language summary

Who can participate

Age range40 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

COPD assessment test(CAT) score

Timeframe: The above test was given to the experimental group and the control group on the first, fourth, and eighth days after the treatment.

Potential of Hydrogen(PH),Partial pressure of oxygen(PO2),Partial pressure of carbon dioxide(PCO2)

Timeframe: The above test was given to the experimental group and the control group on the first, fourth, and eighth days after the treatment.